Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Present

Posted Jun 15 by Two Blokes

WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-t

Source: Two Blokes Trading

Investigational combination of first-in-class bispecifics TALVEY\u00ae and TECVAYLI\u00ae shows deep and durable responses in he

Posted Jun 15 by Two Blokes

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate

Source: Two Blokes Trading

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expre

Posted Jun 15 by Two Blokes

VENLO, Netherlands & WILMINGTON, Del.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt P

Source: Two Blokes Trading

The Fundamental Problem With MicroStrategy's Bitcoin-Buying Plan

Posted Jun 15 by Two Blokes

One of the hottest tech stocks in recent years has been MicroStrategy (MSTR 0.65%), which has rebranded itself

Source: Two Blokes Trading

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or R

Posted Jun 15 by Two Blokes

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/

Source: Two Blokes Trading

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or R

Posted Jun 15 by Two Blokes

Media Release COPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE \u00ae NHL-2 trial show investigation

Source: Two Blokes Trading

Is the Artificial Intelligence Boost Fading for This Top Tech Stock?

Posted Jun 15 by Two Blokes

When artificial intelligence (AI) stocks were all the rage earlier this year, next-generation human resources

Source: Two Blokes Trading

Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Present

Posted Jun 15 by Two Blokes

WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-t

Source: Two Blokes Trading

Investigational combination of first-in-class bispecifics TALVEY\u00ae and TECVAYLI\u00ae shows deep and durable responses in he

Posted Jun 15 by Two Blokes

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate

Source: Two Blokes Trading

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expre

Posted Jun 15 by Two Blokes

VENLO, Netherlands & WILMINGTON, Del.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt P

Source: Two Blokes Trading

Warren Buffett Says Buy This Index Fund. It Could Turn $400 Per Month Into $851,800 With Help From Apple, Nvidia, and Tesla.

Posted Jun 15 by Two Blokes

Warren Buffett has earned a reputation as one of Wall Street's greatest investors. The many acquisitions and s

Source: Two Blokes Trading

2 Artificial Intelligence (AI) Cloud Stocks to Buy in June

Posted Jun 15 by Two Blokes

Artificial intelligence (AI) is providing profitable opportunities for businesses and investors. One market wh

Source: Two Blokes Trading